Ni Jiang

1.8k total citations
88 papers, 1.3k citations indexed

About

Ni Jiang is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ni Jiang has authored 88 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Biomaterials, 21 papers in Biomedical Engineering and 17 papers in Molecular Biology. Recurrent topics in Ni Jiang's work include biodegradable polymer synthesis and properties (16 papers), Nanoparticle-Based Drug Delivery (14 papers) and Nanoplatforms for cancer theranostics (13 papers). Ni Jiang is often cited by papers focused on biodegradable polymer synthesis and properties (16 papers), Nanoparticle-Based Drug Delivery (14 papers) and Nanoplatforms for cancer theranostics (13 papers). Ni Jiang collaborates with scholars based in China, United States and Pakistan. Ni Jiang's co-authors include Jing Yao, Jianping Zhou, Hui Xiong, Zhihua Gan, Shi Du, Xiufeng Ju, Liang Han, Tongtong Miao, Haiyan Chen and Naveed Ullah Khan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Ni Jiang

80 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ni Jiang China 21 448 433 336 307 230 88 1.3k
Janet L. Markman United States 15 429 1.0× 372 0.9× 581 1.7× 382 1.2× 351 1.5× 21 1.5k
Tianyuan Ci China 25 799 1.8× 713 1.6× 455 1.4× 217 0.7× 220 1.0× 43 1.8k
Lixia Feng China 20 386 0.9× 291 0.7× 527 1.6× 190 0.6× 128 0.6× 40 1.3k
Giovanna Lollo France 24 500 1.1× 318 0.7× 515 1.5× 143 0.5× 240 1.0× 51 1.4k
Ming You China 27 483 1.1× 480 1.1× 607 1.8× 264 0.9× 305 1.3× 56 2.0k
Xu Song China 20 487 1.1× 505 1.2× 630 1.9× 163 0.5× 130 0.6× 57 1.4k
Yue Feng China 20 407 0.9× 290 0.7× 397 1.2× 270 0.9× 104 0.5× 51 1.4k
Wenquan Ou South Korea 22 523 1.2× 793 1.8× 544 1.6× 243 0.8× 344 1.5× 34 1.5k
Laura Cabeza Spain 24 603 1.3× 459 1.1× 598 1.8× 248 0.8× 78 0.3× 64 1.5k

Countries citing papers authored by Ni Jiang

Since Specialization
Citations

This map shows the geographic impact of Ni Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Jiang more than expected).

Fields of papers citing papers by Ni Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Jiang. The network helps show where Ni Jiang may publish in the future.

Co-authorship network of co-authors of Ni Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ni Jiang. A scholar is included among the top collaborators of Ni Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni Jiang. Ni Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Min, et al.. (2025). Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review. Frontiers in Public Health. 13. 1658760–1658760.
3.
Yan, Fei, Qifa Liu, Q. Yue, et al.. (2025). From parents to offspring: a comprehensive review of antidepressant-linked reproductive risks. Biology of Reproduction. 113(3). 511–526.
4.
Li, Xingyue, Zhaofei Wang, Ni Jiang, et al.. (2025). HSF-HSP-GST coordinated network underlies ginger's adaptation to combined high-temperature and strong-light stress: Insights from multi-omics integration. Industrial Crops and Products. 236. 121764–121764.
5.
Zhang, Mingjie, Xin Li, Maosheng Zhang, et al.. (2025). A heterogeneous hydrogel patch with mechanical activity and bioactivity for chronic diabetic wound healing. Biomaterials. 324. 123531–123531. 6 indexed citations
6.
7.
Jiang, Ni, et al.. (2024). Outcomes of interprofessional education for pharmacy students: a systematic review. BMC Medical Education. 24(1). 1334–1334. 3 indexed citations
8.
Iqbal, Haroon, Ni Jiang, Naveed Ullah Khan, et al.. (2024). Rationalized landscape on protein-based cancer nanomedicine: Recent progress and challenges. International Journal of Pharmaceutics X. 7. 100238–100238. 13 indexed citations
9.
10.
Li, Junfeng, et al.. (2021). Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies. Digestive Diseases and Sciences. 67(6). 2627–2636. 6 indexed citations
13.
Khan, Naveed Ullah, Ni Jiang, Xiufeng Ju, et al.. (2020). Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment. Acta Pharmaceutica Sinica B. 11(5). 1341–1354. 63 indexed citations
14.
Wang, Xiaoli, Shuo Wang, Michael A. Morse, et al.. (2019). Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients. Journal of Thrombosis and Thrombolysis. 47(4). 505–511. 8 indexed citations
15.
Zhao, Yanhua, Yang Song, Xin Zhou, et al.. (2018). Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS). Clinical & Translational Oncology. 21(6). 721–728. 38 indexed citations
16.
Jiang, Ni, Guoliang Qiao, Xiaoli Wang, et al.. (2017). Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study. Clinical Cancer Research. 23(17). 5066–5073. 64 indexed citations
17.
Zhang, Liting, et al.. (2017). Inhibitors of PARP-1 exert inhibitory effects on the biological characteristics of hepatocellular carcinoma cells in vitro. Molecular Medicine Reports. 16(1). 208–214. 13 indexed citations
18.
Chen, Feng, Menghan Yang, Qingkun Song, et al.. (2017). Enhanced antitumor effects and improved immune status of dendritic cell and cytokine-induced killer cell infusion in advanced cancer patients. Molecular and Clinical Oncology. 7(5). 903–910. 9 indexed citations
19.
Bao, Xu, Meng Gao, Hong Xu, et al.. (2014). A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Drug Development and Industrial Pharmacy. 41(7). 1193–1203. 31 indexed citations
20.
Jiang, Ni. (2011). Clinical Research of Temozolomide Combined with Radiotherapy in the Treatment of Brain Metastasis in Patients with Non-small Cell Lung Cancer. Zhongguo yaofang. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026